Hence, selective natural killer (NK) cell-mediated depletion of the CCR8+ ti-Tregs using newly generated anti-CCR8 nanobody-Fc fusions, caused a significant reduction in tumor growth and synergized with anti-PD-1 therapy, resulting in complete tumor remission and immunological memory. The gene discussed is PDCD1; the disease is neoplasm.